{
  "id": 9328858,
  "title": "Elastic stock price target maintained at $100 by Cantor Fitzgerald",
  "url": "https://urgent.news/2026/09/23/elastic-stock-price-target-maintained-at-100-by-cantor-fitzgerald",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-23T11:48:46.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/elastic-stock-price-target-maintained-at-100-by-cantor-fitzgerald-93CH-4912824"
  },
  "original_language": "en",
  "account": "Investing.com reports that Cantor Fitzgerald has retained a Neutral stock rating and a $100.00 price target for Elastic NV (NYSE:ESTC) shares. The decision comes after Elastic announced its new Metrics offering, which debuted in June 2026. This platform is designed to enhance Elastic's existing logs and traces capabilities, providing customers with real-time monitoring of infrastructure and application performance within a single system. The new Metrics offering features a columnar data store that boosts query performance and storage efficiency, supports high-cardinality workloads, and integrates native PromQL support, pre-built dashboards, and observability content. Cantor Fitzgerald analyst Thomas Blakey maintained the Neutral rating and kept the $100.00 price target unchanged. The stock is currently valued at $89.22, with analysts' price targets ranging from $75 to $130. Elastic's market capitalization stands at $9.37 billion, with a P/E ratio of 25.38. The company's AI-driven analytics platform enables real-time search, analysis, and visualization of enterprise data. Recent financial results show strong performance, with first-quarter fiscal 2027 revenue and sales-led subscription growth accelerating to 15% and 17% in constant currency, respectively. Elastic has raised its guidance, reflecting confidence in its continued growth. Other firms, such as Piper Sandler and Canaccord Genuity, have also raised their price targets for Elastic, citing the company's strong results and high growth in committed remaining performance obligations. Despite a decline in gross margin due to the shift towards AI workloads, these developments suggest a positive outlook for Elastic's future prospects according to analysts.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Cantor Fitzgerald reiterates Compass Therapeutics stock rating",
        "url": "https://urgent.news/2026/09/23/cantor-fitzgerald-reiterates-compass-therapeutics-stock-rating",
        "published": "2026-09-23T11:48:42.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}